Predicting hospitalizations for patients with chronic kidney disease.

Autor: Karpinski S, Sibbel S, Gray K, Walker AG, Luo J, Colson C, Stebbins J, Brunelli SM; Davita, Inc, 825 S 8th St, Ste 300, Minneapolis, MN 55404. Email: Steven.Brunelli@DaVita.com.

Publikováno v: The American journal of managed care [Am J Manag Care] 2023 Sep 01; Vol. 29 (9), pp. e262-e266. Date of Electronic Publication: 2023 Sep 01.

Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.

Autor: Sibbel S; DaVita Clinical Research, Minneapolis, Minnesota., McKeon K; DaVita Clinical Research, Minneapolis, Minnesota., Luo J; DaVita Clinical Research, Minneapolis, Minnesota., Wendt K; DaVita Clinical Research, Minneapolis, Minnesota., Walker AG; DaVita Clinical Research, Minneapolis, Minnesota., Kelley T; DaVita Clinical Research, Minneapolis, Minnesota., Lazar R; DaVita Inc., Denver, Colorado., Zywno ML; DaVita Inc., Denver, Colorado., Connaire JJ; DaVita Clinical Research, Minneapolis, Minnesota., Tentori F; DaVita Clinical Research, Minneapolis, Minnesota., Young A; DaVita Clinical Research, Minneapolis, Minnesota., Brunelli SM; DaVita Clinical Research, Minneapolis, Minnesota.

Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2022 Jan; Vol. 33 (1), pp. 49-57. Date of Electronic Publication: 2021 Nov 17.

Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity.

Autor: Koma T; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Huang C; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Coscia A; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America., Hallam S; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Manning JT; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Maruyama J; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Walker AG; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Miller M; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Smith JN; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Patterson M; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America., Abraham J; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America., Paessler S; Department of Pathology, University of Texas Medical Branch at Galveston, Texas, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2021 Mar 01; Vol. 17 (3), pp. e1009356. Date of Electronic Publication: 2021 Mar 01 (Print Publication: 2021).

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis.

Autor: Chesson CB; Department of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, 08823, USA., Huante M; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Nusbaum RJ; Department of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Walker AG; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, 77555, Texas, USA., Clover TM; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, 77555, Texas, USA., Chinnaswamy J; Department of Pathology and Laboratory Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Endsley JJ; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA. jjendsle@utmb.edu.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, 77555, USA. jjendsle@utmb.edu., Rudra JS; Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, 77555, Texas, USA. jarudra@utmb.edu.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, 77555, USA. jarudra@utmb.edu.

Publikováno v: Scientific reports [Sci Rep] 2018 Aug 21; Vol. 8 (1), pp. 12519. Date of Electronic Publication: 2018 Aug 21.

Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation.

Autor: Walker AG; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Sheffler DJ; Cancer Metabolism and Signaling Networks Program, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Lewis AS; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Dickerson JW; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Foster DJ; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Senter RK; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Moehle MS; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Lv X; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Stansley BJ; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Xiang Z; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Rook JM; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA., Emmitte KA; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA.; Department of Chemistry, Vanderbilt University, Nashville, TN, USA., Lindsley CW; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA.; Department of Chemistry, Vanderbilt University, Nashville, TN, USA., Conn PJ; Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, USA.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2017 Dec; Vol. 42 (13), pp. 2553-2566. Date of Electronic Publication: 2017 Jun 30.